Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung patients may soon do rehab from home via app

NCT ID NCT07666841

Disease control Sponsor: Tel-Aviv Sourasky Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a 12-week tele-pulmonary rehabilitation program, done at home via an app with a physiotherapist, helps people with chronic lung diseases start and stick with rehab better than going to a center. 90 patients will be randomly assigned to either remote rehab or standard center-based care. The goal is to see if remote rehab improves adherence, quality of life, and safety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Tele-pulmonary rehabilitation program (supervised exercise and remote monitoring via app)
What this could lead to
If successful, this could offer a convenient, home-based option for lung rehab, helping more patients stick with treatment and improve their daily lives.
What could go wrong
This is a small, early-stage study (90 participants) comparing remote to center-based rehab. It may not show clear benefits, and remote monitoring might miss some safety issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients meeting the Israeli Health Basket criteria for reimbursement of pulmonary rehabilitation (PR), including one of the following conditions: * COPD with an FEV1 below 50% or with severe exacerbation (hospitalization) in the previous year or two moderate exacerbations in the previous year. * Interstitial lung disease with an FVC below 80% or a DLCO below 60%. * Bronchiectasis with at least two exacerbations in the past year or at least one hospitalization, and an FEV1 below 80%. * Pulmonary arterial hypertension. 2. Willingness to initiate a PR or Tele-PR (TPR) programs. 3. Ability to perform the TPR program or traditional PR activities as assessed by a member of the study team prior to enrollment. 4. Agree to participate, with signed informed consent. Exclusion Criteria: 1. Uncontrolled comorbidity (e.g uncontrolled congestive heart failure) 2. Inability to operate the mobile application. 3. Without a mobile device or computer. 4. A hospitalization in the 2-months prior to randomization. 5. Completed PR program in the last 12 months. 6. Inability to complete 10 repetitions in the 1-minute sit-to-stand test or 5-second single-leg stance 7. Pregnancy 8. Inability to provide informed consent due to impaired decision-making capacity, as determined by the study's capacity assessment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bronchiectasis adult are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bronchiectasis chronic obstructive pulmonary disease COPD, severe early onset interstitial lung disease pulmonary arterial hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bronchiectasis adult COPD (chronic obstructive pulmonary disease) Interstitial lung disease (ILD) Pulmonary arterial hypertension (PAH) Rehabilitation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Barzilai Medical Center

    Ashkelon, Israel

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, 6423906, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.